Cell therapy for muscle regeneration and repair

Physical Medicine and Rehabilitation Clinics of North America

Volumn 16, Issue 4, 2005, Pages 889-907

  Cao, Baohong ^a   Deasy, Bridget M ^a   Pollett, Jonathan ^a   Huard, Johnny ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADOPTIVE IMMUNOTHERAPY; BONE MARROW CELL; CELL MIGRATION; CELL SURVIVAL; CELL TRANSPLANTATION; CIRCULATION; DUCHENNE MUSCULAR DYSTROPHY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FIBROBLAST; HOST; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMOMA; MICROENVIRONMENT; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SATELLITE CELL; SKELETAL MUSCLE;

ANIMALS; CELL SURVIVAL; CELL TRANSPLANTATION; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, ANIMAL; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELLS;

EID: 26244449949     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2005.08.020     Document Type: Review

References (133)

1. E.P. Hoffman, R.H. Brown Jr., and L.M. Kunkel Dystrophin: the protein product of the Duchenne muscular dystrophy locus Cell 51 6 1987 919 928
2. K. Arahata, S. Ishiura, and T. Ishiguro Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide Nature 333 6176 1988 861 863
3. E. Bonilla, C.E. Samitt, and A.F. Miranda Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface Cell 54 4 1988 447 452
4. M. Koenig, E.P. Hoffman, and C.J. Bertelson Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals Cell 50 3 1987 509 517
5. T.A. Partridge Invited review: myoblast transfer: a possible therapy for inherited myopathies? Muscle Nerve 14 3 1991 197 212
6. Y. Hagiwara, Y. Mizuno, and M. Takemitsu Dystrophin-positive muscle fibers following C2 myoblast transplantation into mdx nude mice Acta Neuropathol (Berl) 90 6 1995 592 600
7. J. Huard, J.P. Bouchard, and R. Roy Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy Clin Sci (Lond) 81 2 1991 287 288
8. J.E. Morgan, E.P. Hoffman, and T.A. Partridge Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse J Cell Biol 111 6 Pt 1 1990 2437 2449
9. T.A. Partridge, J.E. Morgan, and G.R. Coulton Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts Nature 337 6203 1989 176 179
10. J. Huard, J.P. Bouchard, and R. Roy Human myoblast transplantation: preliminary results of 4 cases Muscle Nerve 15 5 1992 550 560
11. J. Huard, R. Roy, and J.P. Bouchard Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions Transplant Proc 24 6 1992 3049 3051
12. P.K. Law Pioneering development of myoblast transfer therapy C. Angelini Muscular dystrophy research 1991 Elsevier Science New York 109 116
13. G. Karpati, and G. Acsadi The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases Muscle Nerve 16 11 1993 1141 1153
14. E. Gussoni, G.K. Pavlath, and A.M. Lanctot Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation Nature 356 6368 1992 435 438
15. E. Gussoni, H.M. Blau, and L.M. Kunkel The fate of individual myoblasts after transplantation into muscles of DMD patients Nat Med 3 9 1997 970 977
16. J.P. Tremblay, F. Malouin, and R. Roy Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy Cell Transplant 2 2 1993 99 112
17. J.R. Mendell, J.T. Kissel, and A.A. Amato Myoblast transfer in the treatment of Duchenne's muscular dystrophy N Engl J Med 333 13 1995 832 838
18. J. Huard, R. Roy, and B. Guerette Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection Muscle Nerve 17 2 1994 224 234
19. J.R. Beauchamp, J.E. Morgan, and C.N. Pagel Quantitative studies of efficacy of myoblast transplantation Muscle Nerve 18 Suppl 1994 261
20. Y. Fan, M. Maley, and M. Beilharz Rapid death of injected myoblasts in myoblast transfer therapy Muscle Nerve 19 7 1996 853 860
21. B. Guerette, I. Asselin, and D. Skuk Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation Cell Transplant 6 2 1997 101 107
22. B. Guerette, D. Skuk, and F. Celestin Prevention by anti-LFA-1 of acute myoblast death following transplantation J Immunol 159 5 1997 2522 2531
23. J.P. Tremblay Myoblast transplantation: a brief review of the problems and of some solutions Basic Appl Myol 7 1997 221 230
24. F. Merly, C. Huard, and I. Asselin Anti-inflammatory effect of transforming growth factor-beta1 in myoblast transplantation Transplantation 65 6 1998 793 799
25. J.Y. Lee, Z. Qu-Petersen, and B. Cao Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing J Cell Biol 150 5 2000 1085 1100
26. Z. Qu-Petersen, B. Deasy, and R. Jankowski Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration J Cell Biol 157 5 2002 851 864
27. B. Cao, B. Zheng, and R.J. Jankowski Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential Nat Cell Biol 5 7 2003 640 646
28. P. Bailey, T. Holowacz, and A.B. Lassar The origin of skeletal muscle stem cells in the embryo and the adult Curr Opin Cell Biol 13 6 2001 679 689
29. K. Goldring, T. Partridge, and D. Watt Muscle stem cells J Pathol 197 4 2002 457 467
30. P. Seale, A. Asakura, and M.A. Rudnicki The potential of muscle stem cells Dev Cell 1 3 2001 333 342
31. M.R. Wada, M. Inagawa-Ogashiwa, and S. Shimizu Generation of different fates from multipotent muscle stem cells Development 129 12 2002 2987 2995
32. J.T. Vilquin, I. Kinoshita, and B. Roy Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation J Cell Biol 133 1 1996 185 197
33. K. Leriche-Guerin, L.V. Anderson, and K. Wrogemann Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice Neuromuscul Disord 12 2 2002 167 173
34. S.N. Yao, and K. Kurachi Implanted myoblasts not only fuse with myofibers but also survive as muscle precursor cells J Cell Sci 105 Pt 4 1993 957 963
35. J.G. Gross, and J.E. Morgan Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury Muscle Nerve 22 2 1999 174 185
36. L. Heslop, J.R. Beauchamp, and S. Tajbakhsh Transplanted primary neonatal myoblasts can give rise to functional satellite cells as identified using the Myf5nlacZl + mouse Gene Ther 8 10 2001 778 783
37. Z. Qu, L. Balkir, and J.C. van Deutekom Development of approaches to improve cell survival in myoblast transfer therapy J Cell Biol 142 5 1998 1257 1267
38. S.I. Hodgetts, M.W. Beilharz, and A.A. Scalzo Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4 + and CD8 + cells or Nk1.1 + cells Cell Transplant 9 4 2000 489 502
39. S.I. Hodgetts, M.J. Spencer, and M.D. Grounds A role for natural killer cells in the rapid death of cultured donor myoblasts after transplantation Transplantation 75 6 2003 863 871
40. D. Skuk, N. Caron, and M. Goulet Dynamics of the early immune cellular reactions after myogenic cell transplantation Cell Transplant 11 7 2002 671 681
41. S.I. Hodgetts, and M.D. Grounds Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5 Immunol Cell Biol 79 3 2001 231 239
42. D. Skuk, and J.P. Tremblay Complement deposition and cell death after myoblast transplantation Cell Transplant 7 5 1998 427 434
43. J.T. Vilquin, I. Kinoshita, and R. Roy Cyclophosphamide immunosuppression does not permit successful myoblast allotransplantation in mouse Neuromuscul Disord 5 6 1995 511 517
44. A. Wernig, A. Irintchev, and G. Lange Functional effects of myoblast implantation into histoincompatible mice with or without immunosuppression J Physiol 484 Pt 2 1995 493 504
45. G.K. Pavlath, T.A. Rando, and H.M. Blau Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers J Cell Biol 127 6 Pt 2 1994 1923 1932
46. A. Irintchev, M. Zweyer, and A. Wernig Cellular and molecular reactions in mouse muscles after myoblast implantation J Neurocytol 24 4 1995 319 331
47. O. Hardiman, R.M. Sklar, and R.H. Brown Jr. Direct effects of cyclosporin A and cyclophosphamide on differentiation of normal human myoblasts in culture Neurology 43 7 1993 1432 1434
48. F. Hong, J. Lee, and J.W. Song Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity FASEB J 16 12 2002 1633 1635
49. J.T. Vilquin, I. Asselin, and B. Guerette Myoblast allotransplantation in mice: degree of success varies depending on the efficacy of various immunosuppressive treatments Transplant Proc 26 6 1994 3372 3373
50. D. Skuk, M. Goulet, and B. Roy Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans Exp Neurol 175 1 2002 112 126
51. I. Kinoshita, J.T. Vilquin, and B. Guerette Very efficient myoblast allotransplantation in mice under FK506 immunosuppression Muscle Nerve 17 12 1994 1407 1415
52. J.T. Vilquin, E. Wagner, and I. Kinoshita Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin J Cell Biol 131 4 1995 975 988
53. D. Skuk, B. Roy, and M. Goulet Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle Exp Neurol 155 1 1999 22 30
54. I. Kinoshita, R. Roy, and F.J. Dugre Myoblast transplantation in monkeys: control of immune response by FK506 J Neuropathol Exp Neurol 55 6 1996 687 697
55. D. Skuk, M. Goulet, and B. Roy Myoblast transplantation in whole muscle of nonhuman primates J Neuropathol Exp Neurol 59 3 2000 197 206
56. G. Camirand, N.J. Caron, and I. Asselin Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice Transplantation 72 1 2001 38 44
57. H. Wiendl, M. Mitsdoerffer, and V. Hofmeister The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy Brain 126 Pt 1 2003 176 185
58. G. Keller Embryonic stem cell differentiation: emergence of a new era in biology and medicine Genes Dev 19 10 2005 1129 1155
59. S. Bhagavati, and W. Xu Generation of skeletal muscle from transplanted embryonic stem cells in dystrophic mice Biochem Biophys Res Commun 333 2 2005 644 649
60. P. Seale, and M.A. Rudnicki A new look at the origin, function, and "stem-cell" status of muscle satellite cells Dev Biol 218 2 2000 115 124
61. D.D. Cornelison, and B.J. Wold Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells Dev Biol 191 2 1997 270 283
62. T.J. Hawke, and D.J. Garry Myogenic satellite cells: physiology to molecular biology J Appl Physiol 91 2 2001 534 551
63. P. Seale, L.A. Sabourin, and A. Girgis-Gabardo Pax7 is required for the specification of myogenic satellite cells Cell 102 6 2000 777 786
64. T. Sato, J.H. Laver, and M. Ogawa Reversible expression of CD34 by murine hematopoietic stem cells Blood 94 8 1999 2548 2554
65. J.R. Beauchamp, L. Heslop, and D.S. Yu Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells J Cell Biol 151 6 2000 1221 1234
66. P. Zammit, and J. Beauchamp The skeletal muscle satellite cell: stem cell or son of stem cell? Differentiation 68 4-5 2001 193 204
67. C.A. Collins, I. Olsen, and P.S. Zammit Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche Cell 122 2 2005 289 301
68. nd edition 1994 McGraw-Hill New York 97 118
69. R. Tatsumi, J.E. Anderson, and C.J. Nevoret HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells Dev Biol 194 1 1998 114 128
70. L. Heslop, J.E. Morgan, and T.A. Partridge Evidence for a myogenic stem cell that is exhausted in dystrophic muscle J Cell Sci 113 Pt 12 2000 2299 2308
71. G. Chen, and L.S. Quinn Partial characterization of skeletal myoblast mitogens in mouse crushed muscle extract J Cell Physiol 153 3 1992 563 574
72. R. Bischoff Chemotaxis of skeletal muscle satellite cells Dev Dyn 208 4 1997 505 515
73. S.M. Sheehan, and R.E. Allen Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor J Cell Physiol 181 3 1999 499 506
74. J.P. Brockes, and A. Kumar Plasticity and reprogramming of differentiated cells in amphibian regeneration Nat Rev Mol Cell Biol 3 8 2002 566 574
75. G.R. Rosania, Y.T. Chang, and O. Perez Myoseverin: a microtubule-binding molecule with novel cellular effects Nat Biotechnol 18 3 2000 304 308
76. S.J. Odelberg, A. Kollhoff, and M.T. Keating Dedifferentiation of mammalian myotubes induced by msx1 Cell 103 7 2000 1099 1109
77. C.J. McGann, S.J. Odelberg, and M.T. Keating Mammalian myotube dedifferentiation induced by newt regeneration extract Proc Natl Acad Sci U S A 98 24 2001 13699 13704
78. B.M. Deasy, and J. Huard Gene therapy and tissue engineering based on muscle-derived stem cells Curr Opin Mol Ther 4 4 2002 382 389
79. B.M. Deasy, R.J. Jankowski, and J. Huard Muscle-derived stem cells: characterization and potential for cell-mediated therapy Blood Cells Mol Dis 27 5 2001 924 933
80. R.J. Jankowski, B.M. Deasy, and J. Huard Muscle-derived stem cells Gene Ther 9 10 2002 642 647
81. H. Peng, and J. Huard Muscle-derived stem cells for musculoskeletal tissue regeneration and repair Transpl Immunol 12 3-4 2004 311 319
82. Y. Torrente, J.P. Tremblay, and F. Pisati Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice J Cell Biol 152 2 2001 335 348
83. M.D. Grounds Skeletal muscle precursors do not arise from bone marrow cells Cell Tissue Res 234 3 1983 713 722
84. G.M. Mueller, T. O'Day, and J.F. Watchko Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice Hum Gene Ther 13 9 2002 1081 1090
85. A. Asakura, P. Seale, and A. Girgis-Gabardo Myogenic specification of side population cells in skeletal muscle J Cell Biol 159 1 2002 123 134
86. S. Issarachai, G.V. Priestley, and B. Nakamoto Bone marrow-derived CD45 + and CD45- cells reside in skeletal muscle Blood Cells Mol Dis 29 1 2002 69 72
87. S. Issarachai, G.V. Priestley, and B. Nakamoto Cells with hematopoietic potential residing in muscle are itinerant bone marrow-derived cells Exp Hematol 30 4 2002 366 373
88. J.C. Howell, M.C. Yoder, and E.F. Srour Hematopoietic potential of murine skeletal muscle-derived CD45(-)Sca-1(+)c-kit(-) cells Exp Hematol 30 8 2002 915 924
89. N. Mahmud, P. Weiss, and F. Li Primate skeletal muscle contains cells capable of sustaining in vitro hematopoiesis Exp Hematol 30 8 2002 925 936
90. C. Dell'Agnola, C. Rabascio, and P. Mancuso In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue Exp Hematol 30 8 2002 905 914
91. K.A. Lapidos, Y.E. Chen, and J.U. Earley Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle J Clin Invest 114 11 2004 1577 1585
92. M.A. LaBarge, and H.M. Blau Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury Cell 111 4 2002 589 601
93. T. Tamaki, A. Akatsuka, and K. Ando Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle J Cell Biol 157 4 2002 571 577
94. M. Sampaolesi, Y. Torrente, and A. Innocenzi Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts Science 301 5632 2003 487 492
95. T.A. Robertson, M.D. Grounds, and J.M. Papadimitriou Elucidation of aspects of murine skeletal muscle regeneration using local and whole body irradiation J Anat 181 Pt 2 1992 265 276
96. J.D. Rosenblatt, and D.J. Parry Gamma irradiation prevents compensatory hypertrophy of overloaded mouse extensor digitorum longus muscle J Appl Physiol 73 6 1992 2538 2543
97. E. Schultz, D.L. Jaryszak, and M.C. Gibson Absence of exogenous satellite cell contribution to regeneration of frozen skeletal muscle J Muscle Res Cell Motil 7 4 1986 361 367
98. E. Gussoni, Y. Soneoka, and C.D. Strickland Dystrophin expression in the mdx mouse restored by stem cell transplantation Nature 401 6751 1999 390 394
99. G. Ferrari, G. Cusella-De Angelis, and M. Coletta Muscle regeneration by bone marrow-derived myogenic progenitors Science 279 5356 1998 1528 1530
100. G. Ferrari, A. Stornaiuolo, and F. Mavilio Failure to correct murine muscular dystrophy Nature 411 6841 2001 1014 1015
101. E. Gussoni, R.R. Bennett, and K.R. Muskiewicz Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation J Clin Invest 110 6 2002 807 814
102. R.M. Kapsa, A.F. Quigley, and J. Vadolas Targeted gene correction in the mdx mouse using short DNA fragments: towards application with bone marrow-derived cells for autologous remodeling of dystrophic muscle Gene Ther 9 11 2002 695 699
103. S. Corti, S. Strazzer, and R. Del Bo A subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse Exp Cell Res 277 1 2002 74 85
104. M.A. Goodell, K. Brose, and G. Paradis Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo J Exp Med 183 4 1996 1797 1806
105. S. Zhou, J.J. Morris, and Y. Barnes Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo Proc Natl Acad Sci U S A 99 19 2002 12339 12344
106. S. Zhou, J.D. Schuetz, and K.D. Bunting The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype Nat Med 7 9 2001 1028 1034
107. A. Asakura, and M.A. Rudnicki Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation Exp Hematol 30 11 2002 1339 1345
108. T. Tamaki, A. Akatsuka, and Y. Okada Growth and differentiation potential of main- and side-population cells derived from murine skeletal muscle Exp Cell Res 291 1 2003 83 90
109. S. Oustanina, G. Hause, and T. Braun Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification EMBO J 23 16 2004 3430 3439
110. F. Rivier, O. Alkan, and A.F. Flint Role of bone marrow cell trafficking in replenishing skeletal muscle SP and MP cell populations J Cell Sci 117 Pt 10 2004 1979 1988
111. C. Huard, P.A. Moisset, and A. Dicaire Transplantation of dermal fibroblasts expressing MyoD1 in mouse muscles Biochem Biophys Res Commun 248 3 1998 648 654
112. K. Goldring, G.E. Jones, and R. Thiagarajah The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vitro J Cell Sci 115 Pt 2 2002 355 366
113. A.E. Grigoriadis, J.N. Heersche, and J.E. Aubin Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone J Cell Biol 106 6 1988 2139 2151
114. S. Wakitani, T. Saito, and A.I. Caplan Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine Muscle Nerve 18 12 1995 1417 1426
115. C. De Bari, F. Dell'Accio, and F. Vandenabeele Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane J Cell Biol 160 6 2003 909 918
116. C.P. Ordahl Myogenic shape-shifters J Cell Biol 147 4 1999 695 698
117. M. Tavian, B. Zheng, and E. Oberlin The vascular wall as a source of stem cells Ann NY Acad Sci 1044 2005 41 50
118. E. El Fahime, P. Mills, and J.F. Lafreniere The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation Exp Cell Res 280 2 2002 169 178
119. E. El Fahime, Y. Torrente, and N.J. Caron In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity Exp Cell Res 258 2 2000 279 287
120. Y. Torrente, E. El Fahime, and N.J. Caron Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases Cell Transplant 9 4 2000 539 549
121. J.F. Lafreniere, P. Mills, and J.P. Tremblay Growth factors improve the in vivo migration of human skeletal myoblasts by modulating their endogenous proteolytic activity Transplantation 77 11 2004 1741 1747
122. N.J. Caron, I. Asselin, and G. Morel Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice Cell Transplant 8 5 1999 465 476
123. Y. Torrente, E. El Fahime, and N.J. Caron Tumor necrosis factor-alpha (TNF-alpha) stimulates chemotactic response in mouse myogenic cells Cell Transplant 12 1 2003 91 100
124. J. Huard, S. Verreault, and R. Roy High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice J Clin Invest 93 2 1994 586 599
125. M. Cantini, M.L. Massimino, and C. Catani Gene transfer into satellite cell from regenerating muscle: bupivacaine allows beta-Gal transfection and expression in vitro and in vivo In Vitro Cell Dev Biol Anim 30A 2 1994 131 133
126. C.L. Pin, and P.A. Merrifield Developmental potential of rat L6 myoblasts in vivo following injection into regenerating muscles Dev Biol 188 1 1997 147 166
127. H.S. Alameddine, J.P. Louboutin, and M. Dehaupas Functional recovery induced by satellite cell grafts in irreversibly injured muscles Cell Transplant 3 1 1994 3 14
128. A. Wernig, M. Zweyer, and A. Irintchev Function of skeletal muscle tissue formed after myoblast transplantation into irradiated mouse muscles J Physiol 522 Pt 2 2000 333 345
129. J.C. van Deutekom, S.S. Floyd, and D.K. Booth Implications of maturation for viral gene delivery to skeletal muscle Neuromuscul Disord 8 3-4 1998 135 148
130. J.C. van Deutekom, E.P. Hoffman, and J. Huard Muscle maturation: implications for gene therapy Mol Med Today 4 5 1998 214 220
131. A.M. Neumeyer, D.M. DiGregorio, and R.H. Brown Jr. Arterial delivery of myoblasts to skeletal muscle Neurology 42 12 1992 2258 2262
132. Y. Li, W. Foster, and B.M. Deasy Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis Am J Pathol 164 3 2004 1007 1019
133. Y. Li, and J. Huard Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle Am J Pathol 161 3 2002 895 907